Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Pfizer BNT162b2"'
Autor:
Safi Ur Rehman Daim, MD, Aya Alsermani, MBBS, Renad Khalid Althomali, MBBS, Muhammad Fawad Ashraf, MD, Maamoun AlSermani, MBBS
Publikováno v:
Radiology Case Reports, Vol 19, Iss 9, Pp 4087-4090 (2024)
COVID-19 vaccines, a cornerstone of the fight against the disease have generally proven to be safe with most commonly reported side effects being mild and self-limiting. Uncommon severe adverse effects like thromboembolism have been reported during p
Externí odkaz:
https://doaj.org/article/e95fe61a384d45899af64a404e28fed5
Autor:
Dhuha Ali, Ghada Taha
Publikováno v:
Microbes and Infectious Diseases, Vol 5, Iss 1, Pp 80-88 (2024)
Background: The most widely used vaccination against SARS-associated coronavirus (SARS-CoV-2) is the Pfizer vaccine, which provides protection against this virus. However, its ability to safeguard the oral cavity is unclear, and neither are the exact
Externí odkaz:
https://doaj.org/article/bcc27acca290444591b4dc8a7d252fdd
Autor:
Dhuha Ali, Ghada Taha
Publikováno v:
مجلة كلية الطب, Vol 65, Iss 2 (2023)
Background: The most widely used vaccination against SARS-associated coronavirus (SARS-CoV-2) is the Pfizer vaccine, which provides protection against this virus. However, its ability to safeguard the oral cavity is unclear, and neither are the exact
Externí odkaz:
https://doaj.org/article/e7c034ff0b0b4f2c99d5b43a79336c7d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hao Zhou, Belinda M. Dcosta, Marie I. Samanovic, Mark J. Mulligan, Nathaniel R. Landau, Takuya Tada
Publikováno v:
mBio, Vol 12, Iss 4 (2021)
ABSTRACT DNA sequence analysis recently identified the novel SARS-CoV-2 variant B.1.526 that is spreading at an alarming rate in the New York City area. Two versions of the variant were identified, both with the prevalent D614G mutation in the spike
Externí odkaz:
https://doaj.org/article/d27f99fff4a1464d856ab08b87f4e537
Autor:
Cornelius Knabbe, Udo Boeken, Rasmus Rivinius, Benjamin Müller, Angelika Costard-Jäckle, Zdenek Provaznik, René Schramm, Bastian Fischer, Assad Haneya, Jan Gummert
Publikováno v:
Clinical Research in Cardiology
Aims Immunocompromised patients have been excluded from studies of SARS-CoV-2 messenger RNA vaccines. The immune response to vaccines against other infectious agents has been shown to be blunted in such patients. We aimed to analyse the humoral and c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0fe283cf2322b19a025d3ff191bbf2b
http://europepmc.org/articles/PMC8267767
http://europepmc.org/articles/PMC8267767
Autor:
Michael Halberthal, Yael Shachor-Meyouhas, Gila Hyams, Michal Mekel, Marielle Kaplan, Moran Szwarcwort-Cohen, Khetam Hussein, Netanel A. Horowitz, Avi Weissman, Halima Dabaja-Younis
Publikováno v:
Vaccine
Introduction The coronavirus disease 2019 (COVID-19) pandemic has led to worldwide vaccination development efforts. In December 2020 the Pfizer BNT162b2 vaccine was approved in the United States. This study describes the first BNT162b2 vaccine dose e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e83cff1ad48fe08f8e38dfbfa90e5ee
http://europepmc.org/articles/PMC8537975
http://europepmc.org/articles/PMC8537975
Autor:
George Sigal, Prabhu S. Arunachalam, Chunfeng Li, Mark M. Davis, Massa J. Shoura, Bali Pulendran, Emily Haraguchi, James L. Wilbur, Ramona A. Hoh, Kari C. Nadeau, Benjamin A. Pinsky, Alexandra S. Lee, Fan Yang, Sandra C. A. Nielsen, Oliver F. Wirz, Vamsee Mallajosyula, Jacob N. Wohlstadter, Scott D. Boyd, Katharina Roeltgen, Fei Gao
Publikováno v:
medRxiv
article-version (status) pre
article-version (number) 1
article-version (status) pre
article-version (number) 1
During the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, new vaccine strategies including lipid nanoparticle delivery of antigen encoding RNA have been deployed globally. The BioNTech/Pfizer mRNA vaccine BNT162b2 encoding SAR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82c5ab84c6656bd6bf6a1ec27b8760c1
https://pubmed.ncbi.nlm.nih.gov/33851181
https://pubmed.ncbi.nlm.nih.gov/33851181
Autor:
Nathaniel R. Landau, Takuya Tada, Belinda M Dcosta, Marie I. Samanovic, Hao Zhou, Mark J. Mulligan
Publikováno v:
mBio
bioRxiv
mBio, Vol 12, Iss 4 (2021)
bioRxiv
mBio, Vol 12, Iss 4 (2021)
DNA sequence analysis recently identified the novel SARS-CoV-2 variant B.1.526 that is spreading at an alarming rate in the New York City area. Two versions of the variant were identified, both with the prevalent D614G mutation in the spike protein,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31ffb601241ec0bd696b19b99bd126bd
https://pubmed.ncbi.nlm.nih.gov/34311587
https://pubmed.ncbi.nlm.nih.gov/34311587
Autor:
Amber Cornelius, Nathaniel R. Landau, Mark J. Mulligan, Takuya Tada, Belinda M Dcosta, Marie I. Samanovic-Golden, Ramin S. Herati
Publikováno v:
mBio
The increasing prevalence of SARS-CoV-2 variants with mutations in the spike protein has raised concerns that recovered individuals may not be protected from reinfection and that current vaccines will become less effective. The B.1.1.7 isolate identi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f9c5f90b9df605a78764add6507a3f8
https://doi.org/10.1101/2021.02.05.430003
https://doi.org/10.1101/2021.02.05.430003
